Serum chemokines and cytokines in CLL patients treated with duvelisib, a PI3K-δ,γ inhibitor Meeting Abstract


Authors: Douglas, M.; Allen, K.; Sweeney, J.; O'Brien, S. M.; Flinn, I.; Horwitz, S. M.; Byrd, J. C.; Patel, M. R.; Kahl, B. S.; Foss, F. M.; Porcu, P.; Kelly, V.; Stern, H.
Abstract Title: Serum chemokines and cytokines in CLL patients treated with duvelisib, a PI3K-δ,γ inhibitor
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901608
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.7072
Notes: Meeting Abstract: 7072 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    645 Horwitz